Vertex Stock Muted After Beating Quarterly Views; What Could Spark Shares?

Vertex Pharmaceuticals easily cleared Wall Street’s first-quarter projections Thursday — prodding VRTX stock up marginally in after-hours action. The company kept its product sales outlook.
Read More